Susan Rodriguez

Insider Reports History

Location
Fremont, CA
Signature
Lisa Zvonik by power of attorney for Susan Rodriguez
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Susan Rodriguez:

Company Role Class Num Shares Value Price $ Report Date Ownership
ARDELYX, INC. Chief Commercial Officer Common Stock 449,092 $3,507,858 $7.81 21 May 2024 Direct
Veradigm Inc. Director Common Stock 88,618 $381,057 $4.30 02 Jun 2025 Direct
ARDELYX, INC. Chief Commercial Officer Stock Option (Right to Buy) 145,000 $336,400 $2.32 16 Jan 2024 Direct
HERON THERAPEUTICS, INC. /DE/ Director Common Stock 87,180 $230,155 $2.64 31 Jan 2025 Direct
HERON THERAPEUTICS, INC. /DE/ Director Stock Option (Right to Buy) 35,900 $62,107 $1.73 31 Jan 2025 Direct
AVADEL PHARMACEUTICALS PLC Chief Operating Officer Stock Option (Right to Buy) 300,000 13 May 2025 Direct

Insider Reports Filed by Susan Rodriguez

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MDRX Veradigm Inc. 02 Jun 2025 1 +$200,002 4 Director 03 Jun 2025, 19:43
AVDL AVADEL PHARMACEUTICALS PLC 13 May 2025 1 $0 4 Chief Operating Officer 13 May 2025, 18:01
AVDL AVADEL PHARMACEUTICALS PLC 13 May 2025 0 $0 3 Chief Operating Officer 13 May 2025, 18:00
HRTX HERON THERAPEUTICS, INC. /DE/ 31 Jan 2025 2 $0 4/A Director 04 Feb 2025, 17:27
HRTX HERON THERAPEUTICS, INC. /DE/ 30 Jan 2025 2 +$62,107 4 Director 03 Feb 2025, 11:33
MDRX Veradigm Inc. 31 May 2024 1 $0 4 Director 20 Jun 2024, 17:00
ARDX ARDELYX, INC. 21 May 2024 1 -$52,357 4 Chief Commercial Officer 23 May 2024, 16:17
ARDX ARDELYX, INC. 20 Feb 2024 1 -$60,594 4 Chief Commercial Officer 22 Feb 2024, 16:56
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Jan 2024 2 $0 4 Director 19 Jan 2024, 21:04
ARDX ARDELYX, INC. 16 Jan 2024 2 $0 4 Chief Commercial Officer 18 Jan 2024, 16:37
ARDX ARDELYX, INC. 20 Nov 2023 1 -$20,563 4 Chief Commercial Officer 22 Nov 2023, 17:20
ARDX ARDELYX, INC. 21 Aug 2023 1 -$16,811 4 Chief Commercial Officer 23 Aug 2023, 17:48
ARDX ARDELYX, INC. 23 May 2023 1 -$17,210 4 Chief Commercial Officer 25 May 2023, 08:52
ARDX ARDELYX, INC. 21 Feb 2023 1 -$16,764 4 Chief Commercial Officer 02 Mar 2023, 15:36
MDRX Veradigm Inc. 17 Feb 2023 0 $0 3 Director 27 Feb 2023, 16:27
ARDX ARDELYX, INC. 05 Jan 2023 2 $0 4 Chief Commercial Officer 06 Jan 2023, 15:24
HRTX HERON THERAPEUTICS, INC. /DE/ 16 Dec 2022 2 $0 4 Director 20 Dec 2022, 16:21
ARDX ARDELYX, INC. 22 Nov 2022 3 -$6,736 4 Chief Commercial Officer 23 Nov 2022, 15:15
ARDX ARDELYX, INC. 22 Aug 2022 2 -$3,364 4 Chief Commercial Officer 24 Aug 2022, 17:45
ARDX ARDELYX, INC. 06 Jun 2022 2 -$28,574 4 Chief Commercial Officer 08 Jun 2022, 20:02
ARDX ARDELYX, INC. 20 May 2022 1 -$2,300 4 Chief Commercial Officer 23 May 2022, 16:35
ARDX ARDELYX, INC. 22 Feb 2022 1 -$2,278 4 Chief Commercial Officer 25 Feb 2022, 15:54
ARDX ARDELYX, INC. 06 Jan 2022 2 $0 4 Chief Commercial Officer 12 Jan 2022, 18:47
HRTX HERON THERAPEUTICS, INC. /DE/ 22 Dec 2021 2 $0 4 Director 23 Dec 2021, 17:58
ARDX ARDELYX, INC. 22 Nov 2021 1 -$638 4 Chief Commercial Officer 24 Nov 2021, 15:08
ARDX ARDELYX, INC. 08 Oct 2021 1 $0 4 Chief Commercial Officer 29 Oct 2021, 19:56
HRTX HERON THERAPEUTICS, INC. /DE/ 20 Sep 2021 0 $0 3 Director 29 Sep 2021, 16:18
ARDX ARDELYX, INC. 20 Aug 2021 1 -$832 4 Chief Commercial Officer 24 Aug 2021, 18:07
ARDX ARDELYX, INC. 20 May 2021 1 -$4,331 4 Chief Commercial Officer 21 May 2021, 16:49